质谱成像市场规模、份额和成长分析：按产品类型、技术、应用、最终用户和地区划分－2026-2033年产业预测

2024年全球质谱成像市场价值为30亿美元，预计2025年将成长至32.7亿美元，到2033年将成长至65.7亿美元。预测期（2026-2033年）的复合年增长率预计为9.1%。

全球质谱成像市场的主要驱动力是生命科学和临床研究中对具有空间分辨率的分子数据日益增长的需求。透过将质谱和成像技术结合，该技术能够对组织切片上的代谢物、脂质、胜肽和药物进行精细的映射，超越了传统检测方法的能力。这些洞察有助于生物标记的发现、优化手术流程，并为个人化治疗方案提供资讯。电离技术和软体的进步提高了灵敏度和空间分辨率，推动了质谱成像技术的应用，尤其是在製药公司和医疗机构中。人工智慧的整合透过简化数据解读和支援生物标记的发现，增强了临床应用，最终加速了这项强大工具的普及，并提升了其在全球诊断和精准医疗领域的应用。

全球质谱成像市场驱动因素

全球质谱成像市场的主要驱动因素之一是蛋白质体学、代谢体学和药物研发等各个领域对先进分析技术日益增长的需求。随着研究人员和製药公司寻求了解复杂的生物过程并提高药物疗效，质谱成像技术能够以无与伦比的空间分辨率和灵敏度对组织内的生物分子进行分析。这种可视化分子分布的能力与疾病的发病机制和进展直接相关，有助于实现个人化医疗。此外，技术的不断进步正在提升质谱成像的功能和可用性，进一步加速其在各种研究和临床应用领域的普及。

全球质谱成像市场面临的限制因素

全球质谱成像市场的主要限制因素之一是先进质谱仪的引进和维护高成本。除了购买尖端设备所需的初始投资外，持续的维护、技术支援和耗材费用也可能成为小规模实验室和研究机构的一大障碍。此外，质谱技术的复杂性要求操作人员具备操作和资料解读能力，这进一步增加了成本。这些资金限制会限制市场成长，尤其是在资金往往有限的发展中地区。

全球质谱成像市场趋势

在全球质谱成像市场，空间多体学方法的融合已成为一个显着趋势。这种方法将质谱成像与互补的空间体学技术结合，透过产生多维分子图谱来阐明组织结构中蛋白质、转录物和代谢物的共定位，从而加深对生物学的理解。这一趋势不仅强化了其在生物标记发现和药物分布研究方面的应用，也促进了可互通工作流程和混合平台的开发。仪器供应商和软体供应商之间的合作对于建立先进的资料整合工具和标准化流程至关重要，这有助于这些工具和流程在需要分子层级背景资讯的多个研究领域、核心机构和跨学科专案中广泛应用。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球质谱成像市场规模：依产品类型及复合年增长率划分（2026-2033 年）

• 装置
  • 高分辨率质谱仪
  • 成像质谱仪
  • 基质辅助雷射解吸/电离飞行时间质谱系统
  • 液相层析-质谱联用系统
  • 四极飞行时间质谱仪
  • 串联式质谱质谱仪
• 消耗品
  • 试剂和化学品
  • 样品製备试剂盒
  • 质谱板和载玻片
  • 校准标准物质
  • 溶剂和缓衝液
• 服务
  • 安装和维护服务
  • 数据分析与软体服务
  • 培训和支援服务
  • 咨询和客製化服务

全球质谱成像市场规模：按技术和复合年增长率划分（2026-2033 年）

• 基质辅助雷射解吸和电离（MALDI）
• 二次离子质谱法（SIMS）
• 解吸电洒电离（DESI）
• 磁扇形质谱法
• 飞行时间质谱法（TOFMS）
• 其他技术

全球质谱成像市场规模：按应用和复合年增长率划分（2026-2033 年）

• 蛋白质体学
• 代谢体学
• 聚醣分析
• 其他用途

全球质谱成像市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 製药和生物技术公司
• 政府机构和学术机构
• 其他最终用户

全球质谱成像市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific
• Sciex
• Waters Corporation
• Bruker Corporation
• Agilent Technologies
• PerkinElmer
• Shimadzu Corporation
• AB Sciex
• JEOL Ltd.
• Aglient
• IonBench
• Analytik Jena
• Vanquish
• MassTech
• BioTools
• Hitachi High-Technologies Corporation
• Hyperion
• Tofwerk AG
• IonQ
• Evosep

结论与建议

Global Mass Spectrometry Imaging Market size was valued at USD 3.0 Billion in 2024 and is poised to grow from USD 3.27 Billion in 2025 to USD 6.57 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global mass spectrometry imaging market is primarily driven by the increasing demand for spatially resolved molecular data in life sciences and clinical research. By combining mass spectrometry with imaging, this technology allows for detailed mapping of metabolites, lipids, peptides, and drugs on tissue sections, surpassing the capabilities of traditional assays. Such insights facilitate biomarker discovery, optimize surgical procedures, and inform personalized treatment options. As advancements in ionization techniques and software have improved sensitivity and spatial resolution, the adoption of mass spectrometry imaging has surged, particularly among pharmaceutical companies and healthcare institutions. The integration of AI enhances clinical applications by streamlining data interpretation and supporting biomarker discovery, ultimately making this powerful tool more accessible and boosting its presence in diagnostics and precision medicine across global markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mass Spectrometry Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mass Spectrometry Imaging Market Segments Analysis

Global mass spectrometry imaging market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into Instruments, Consumables and Services. Based on technology, the market is segmented into Matrix-Assisted Laser Desorption Or Ionization (MALDI), Secondary Ion Mass Spectrometry (SIMS), Desorption Electrospray Ionization (DESI), Magnetic Sector Mass Spectrometry, Time-of-Flight Mass Spectrometry (TOFMS) and Other Technologies. Based on application, the market is segmented into Proteomics, Metabolomics, Glycomics and Other Applications. Based on end-user, the market is segmented into Pharmaceutical and Biotechnology Companies, Government and Academic Institutions and Other End-Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mass Spectrometry Imaging Market

One of the key market drivers for the global mass spectrometry imaging market is the increasing demand for advanced analytical techniques in various fields, such as proteomics, metabolomics, and drug development. As researchers and pharmaceutical companies seek to understand complex biological processes and improve drug efficacy, mass spectrometry imaging provides unparalleled spatial resolution and sensitivity for profiling biomolecules within tissues. This ability to visualize molecular distributions directly correlates with disease pathology and progression facilitates personalized medicine approaches. Additionally, ongoing technological advancements are enhancing the capabilities and accessibility of mass spectrometry imaging, further propelling its adoption across various research and clinical applications.

Restraints in the Global Mass Spectrometry Imaging Market

One key market restraint for the global mass spectrometry imaging market is the high cost associated with the acquisition and maintenance of advanced mass spectrometry equipment. The initial investment required for state-of-the-art instruments, along with the ongoing expenses for maintenance, technical support, and consumables, can be a barrier for smaller laboratories and research institutions. Additionally, the complexity of mass spectrometry technology necessitates skilled personnel for operation and data interpretation, further increasing costs. These financial constraints may limit market growth, particularly in developing regions where funding for advanced analytical technologies is often restricted.

Market Trends of the Global Mass Spectrometry Imaging Market

The Global Mass Spectrometry Imaging market is experiencing a significant trend towards the convergence of spatial multi-omics approaches, wherein mass spectrometry imaging is integrated with complementary spatial omics technologies. This integration is yielding multidimensional molecular maps that elucidate the co-localization of proteins, transcripts, and metabolites in tissue structures, thereby deepening our biological understanding. This trend not only enhances applications in biomarker discovery and drug distribution studies but also fosters the development of interoperable workflows and hybrid platforms. The collaborative efforts between instrument vendors and software providers are pivotal in creating advanced data fusion tools and standardized pipelines, facilitating broader adoption across diverse research arenas, core facilities, and interdisciplinary initiatives requiring contextual molecular insights.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Mass Spectrometry Imaging Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
  • High-Resolution Mass Spectrometers
  • Imaging Mass Spectrometers
  • Matrix-Assisted Laser Desorption Or Ionization Time-of-Flight System
  • Liquid Chromatography-Mass Spectrometry System
  • Quadrupole Time-of-Flight Mass Spectrometers
  • Tandem Mass Spectrometers
• Consumables
  • Reagents And Chemicals
  • Sample Preparation Kits
  • Mass Spectrometry Plates And Slides
  • Calibration Standards
  • Solvents And Buffers
• Services
  • Installation And Maintenance Services
  • Data Analysis And Software Services
  • Training And Support Services
  • Consultation And Customization Services

Global Mass Spectrometry Imaging Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Matrix-Assisted Laser Desorption Or Ionization (MALDI)
• Secondary Ion Mass Spectrometry (SIMS)
• Desorption Electrospray Ionization (DESI)
• Magnetic Sector Mass Spectrometry
• Time-of-Flight Mass Spectrometry (TOFMS)
• Other Technologies

Global Mass Spectrometry Imaging Market Size by Application & CAGR (2026-2033)

• Market Overview
• Proteomics
• Metabolomics
• Glycomics
• Other Applications

Global Mass Spectrometry Imaging Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Government and Academic Institutions
• Other End-Users

Global Mass Spectrometry Imaging Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AB Sciex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JEOL Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aglient
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IonBench
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vanquish
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MassTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTools
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi High-Technologies Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hyperion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tofwerk AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IonQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evosep
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations